ERO1A and neoplasm: Combined assessment of ERO1A expression and CD163&lt;sup&gt;+&lt;/sup&gt; tumor-associated macrophage infiltration is superior to traditional assessment methods in predicting clear cell renal cell carcinoma prognosis.